Registration studies with Nobivac® Bb for cats

Bordetella bronchiseptica is widespread in the feline population
Our studies show that Nobivac® Bb for cats is reassuringly safe and effective.

It is now known that Bordetella bronchiseptica is widespread in the feline population and associated with upper respiratory tract disease (URTD). Nobivac® Bb for cats is the first and only vaccine available to protect cats against this disease. Our registration studies show that Nobivac® Bb for cats is safe and provides protection for at least one year within 72 hours of administration. These include studies on: